AVITA Medical (NASDAQ:RCEL) reported its Q3 earnings results on Thursday, May 12, 2022 at 04:00 PM.
Here’s what investors need to know about the announcement.
Earnings
AVITA Medical beat estimated earnings by 5.0%, reporting an EPS of $-0.38 versus an estimate of $-0.4.
Revenue was down $1.23 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.05 which was followed by a 14.89% increase in the share price the next day.
Here’s a look at AVITA Medical’s past performance:
| Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.39 | -0.38 | -0.29 | -0.33 |
| EPS Actual | -0.34 | -0.24 | -0.19 | -0.26 |
| Revenue Estimate | 7.00M | 7.10M | 7.88M | 6.37M |
| Revenue Actual | 6.94M | 7.02M | 10.30M | 8.77M |
To track all earnings releases for AVITA Medical visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
